Company Filing History:
Years Active: 2017-2020
Title: Gernot Schabbauer: Innovator in Immune Modulation
Introduction
Gernot Schabbauer is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of immunology, particularly through his innovative methods and compositions aimed at modulating the immune system. With a total of 3 patents to his name, Schabbauer's work is paving the way for advancements in medical treatments.
Latest Patents
Schabbauer's latest patents focus on methods and compositions for modulating the immune system using arginase I. These patents disclose recombinant Arginase I proteins that are capable of depleting plasma arginine levels in a subject. The methods and compositions developed can effectively modulate the activity of the immune system, which is beneficial in treating immune disorders and preventing the rejection of transplanted organs, tissues, or cells. Additionally, these innovations can be utilized to treat bone conditions in subjects.
Career Highlights
Gernot Schabbauer is currently associated with Bio-Cancer Treatment International Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving health outcomes through innovative scientific approaches.
Collaborations
Schabbauer collaborates with esteemed colleagues, including Emine Sahin-Heco and Paul Cheng, to further enhance the impact of his research in the field of immunology.
Conclusion
Gernot Schabbauer's contributions to immune modulation through his patented methods and compositions highlight his role as a leading innovator in the medical field. His ongoing work promises to bring significant advancements in the treatment of immune-related disorders.